Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Oral tofacitinib successfully treated total body hair loss in one patient.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

JAK inhibitors offer new hope for treating severe alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Dupilumab may help regrow hair in people with severe alopecia.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib may help people with long-term alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.